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Abstract
There is considerable interest in the use of heavy atom nanoparticles as theranostic contrast agents 
due to their high radiation cross-section compared to soft tissue. However, published studies have 
primarily focused on applications of gold nanoparticles. This study applies Monte Carlo radiation 
transport modelling using Geant4 to evaluate the macro- and micro-scale radiation dose 
enhancement following X-ray irradiation with both imaging and therapeutic energies on 
nanoparticles consisting of stable elements heavier than silicon. An approach based on the Local 
Effect Model was also used to assess potential biological impacts. While macroscopic dose 
enhancement is well predicted by simple absorption cross-sections, nanoscale dose deposition has a 
much more complex dependency on atomic number, with local maxima around germanium (Z=32) 
and gadolinium (Z=64), driven by variations in secondary Auger electron spectra, which translate 
into significant variations in biological effectiveness. These differences may provide a valuable tool
for predicting and elucidating fundamental mechanisms of these agents as they move towards 
clinical application. 
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Introduction
Radiotherapy's primary objective is to selectively deliver high doses of radiation to tumours while 
sparing surrounding normal tissues. Clinical progress has been driven in recent years by significant 
technical advances in radiation delivery, with advanced techniques such as Intensity Modulated 
Radiotherapy (IMRT) and Volumetric Arc Therapy (VMAT) enabling highly conformal radiation 
delivery. These techniques are increasingly coupled with image guidance, currently using single and
dual energy kV X-rays and with interest into expanding these techniques to incorporate Linac-MRI 
approaches in the future.  
Despite these advances, tumour dose escalation is often limited by the presence of nearby organs at 
risk, as inherent uncertainties in treatment delivery place strict limits on prescription doses to 
minimise radiotherapy-related side effects. As a result, there is a significant interest in techniques 
which further improve dose specificity to tumour volumes.
One approach to selectively spare healthy tissue is through the introduction of contrast agents – 
materials of high atomic number (Z) which strongly absorb ionising radiation. If these particles can 
be delivered preferentially to tumour volumes, they can selectively increase the target's absorption, 
offering both improved image contrast and dose conformality.
This approach has long been hampered by the lack of a suitable tumour-specific mechanism for 
delivering these contrast agents, but in recent years there has been significant interest in the 
application of high-Z nanoparticles for this purpose, following early work demonstrating the 
efficacy of gold nanoparticles as radiosensitising agents in mice (1). These nanoparticles were able 
to exploit the leaky tumour vasculature to achieve selective uptake in tumour volumes via the 
enhanced permeability and retention effect (EPR), and when combined with radiotherapy gave 
significant improvements in tumour control and overall survival in mice compared to radiotherapy 
alone.
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Following this early work, there have been several hundred publications investigating the 
radiosensitising properties of gold nanoparticles, studying the impact of factors such a particle size, 
shape, and surface coating (2). These investigations made use of both mathematical modelling of 
their interactions with incident ionising radiation (3–7) as well as numerous in vitro and in vivo 
experimental studies (8–11). 
Despite this, it remains an open question as to whether gold is the optimum material for this 
purpose. Only a handful of other elements have been investigated for use as radiosensitisers 
(including platinum, hafnium, gadolinium, and iron (12–16) ), and there have been no systematic 
experimental or theoretical comparisons between different materials.
The focus on gold largely stems from the original rationale for the use of high-Z contrast agents. If 
sensitisation derives from increased absorption, then it is reasonable to seek to maximize the 
nanoparticles' atomic number, as X-ray mass energy absorption coefficients increase strongly with 
increasing atomic number (with the photoelectric effect scaling as Z3). Thus gold, being 
biocompatible and one of the heaviest stable elements, was a natural choice.
While these assumptions are known to be valid for imaging applications, which are driven primarily
by the attenuation and absorption coefficients of the contrast agent, experimental studies of gold 
nanoparticle radiosensitisers have challenged this view for therapy. In this context, it is important to
distinguish between dose enhancement – that is, the increase in energy deposited in the target 
volume due to the presence of the nanoparticles – and radiosensitisation, the increase in the 
biological effects of radiation observed when used in combination with nanoparticles. Although it 
was originally expected that these effects should be closely related for high-Z contrast agents, 
experimental investigations have shown that the radiosensitising effects of gold nanoparticles are 
very poorly correlated with macroscopic dosimetric calculations (2), with little or no relationship 
apparent between calculated dose enhancement and observed biological effects. In particular, 
radiosensitisation is often seen to be significantly greater than the increase in physical dose, and 
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effects are seen using clinical megavoltage X-ray sources where the addition of nanoparticles leads 
to only negligible increases in the total dose. These results indicate that macroscopic dose 
enhancement alone is not a useful predictor of radiosensitisation across different cell lines and 
nanoparticle preparations.
As a result, several new hypotheses have been advanced to attempt to understand and predict these 
biological effects. One key observation from modelling of nanoparticle-radiation interactions is 
that, on the micro- and nano-scale, the dose distribution around gold nanoparticles is highly 
heterogeneous. Extremely high doses are deposited in the immediate vicinity of the nanoparticle, 
driven by the large number of low-energy secondary Auger electrons produced following ionisation 
in high-Z elements (17–19). Similar heterogeneous dose distributions are seen in ion-based 
radiotherapy, where techniques such as the Local Effect Model (LEM) have been developed to 
explain their superior biological effectiveness compared to relatively uniform X-ray exposures (20, 
21). Analysis of nanoparticle-enhanced therapy based on these techniques have shown a similar 
increase in biological impact, potentially explaining some of the observed sensitisation in gold 
nanoparticle enhanced radiotherapy (22–24)
If nanoscale dose deposition is an important factor in the radiosensitising impact of nanoparticle 
contrast agents, then it is no longer clear that the heaviest elements are the best choice, as these 
nanoscale effects are poorly characterised by macroscopic dose, and care must be taken to 
incorporate the particles' potentially different impacts when exposed to X-ray imaging and 
therapeutic energies.
This work presents the first systematic computational study of the impact of elemental composition 
on nanoparticle-radiation interactions for both kilovoltage and megavoltage X-ray exposures, 
spanning elements from silicon (Z=14) to mercury (Z=80). While some of these elements may not 
be suitable for use as nanoparticle contrast agents, the full range of elements in this range was 
investigated to fully explore the underlying mechanisms of dose deposition.
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For all nanoparticles, these simulations calculated total dose deposition, nanoscale dose distribution,
and biological effects assessed through an approach based on the Local Effect Model. Complete 
reference data sets for these particles are also made available in the Supporting Information.
Results
Macroscopic analysis
Figure 1 illustrates the mass energy absorption coefficient for soft tissue and a series of high-Z 
materials (Gold, Hafnium, Gadolinium and Iodine) which are of interest as contrast agents, along 
with their ratio which is a guide to macroscopic dose enhancement. Although there is a general 
trend for higher Z atoms to see greater absorption at keV energies, this is not universally true as the 
positioning of the K and L absorption edges lead to sharp discontinuities which can often lead to 
lighter elements seeing stronger absorption. Thus even in the relatively simple macroscopic case, 
optimum contrast is not necessarily delivered by the material with the greatest atomic number.
This is further illustrated in Figure 2, which maps the relative potential dose enhancement per unit 
mass of contrast agent for monochromatic X-ray exposures. At low energies, these effects are 
dominated by bands representing elements which are strongly absorbing due to M, L, or K edge 
effects (respectively, from low to high energy). However, it can be seen that these bands are quite 
broad, with large numbers of elements within 25% of the maximum dose enhancement at a wide 
range of energies. 
Higher energies see significantly less material dependence, as these effects are dominated by 
Compton interactions which are largely independent of atomic number, with all elements offering 
within 20% of the maximum contrast in the Compton dominated region from 1 to 5 MeV. 
Notably, it can also be seen that all element with Z>=60 are within approximately a factor of 2 of 
the maximum achievable macroscopic contrast at all energies >= 10 keV. This suggests that even in 
imaging applications there is value in further investigating materials in this range, as the small 
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increase in concentration needed to drive macroscopic effects may be offset by the greater 
flexibility offered by a wider range of candidate materials for nanoparticle design.
Contributing processes on the macro- and nano-scale.
A breakdown of the processes contributing to both total and local (within 1 μm) dose deposition is 
shown in Figure 3, for 20 nm diameter nanoparticles exposed to either tuned kilovoltage irradiation 
(left) or a 6 MV Linac spectrum at the 80% PDD (right). For kilovoltage interactions, the total 
energy deposition is dominated by photoelectrons and fluorescence photons at low and high 
energies respectively, with a small contribution of Auger electrons and Compton scatter. However, 
considering only dose deposited within 1 μm of the nanoparticle, Auger electrons are the primary 
source of energy deposition for all elements, as photoelectrons and fluorescence photons have too 
long a range to deposit significant dose in the vicinity of the nanoparticle.  Notably, unlike other 
processes Auger energy distribution has a multi-peaked behaviour on this scale, driven by the 
variation in Auger electron yield, energy and range as a function of atomic number.
In megavoltage exposures, total energy deposits are dominated by Compton scatter and there is now
a significant contribution from secondary electrons generated by the beam interacting with the 
surrounding water volume, although the contributions of photoelectrons and fluorescence does 
increase for the heaviest elements. The distribution is again noticeably different on the local scale, 
where electron impact remains a dominant contribution but the effects of Compton electrons are 
mitigated due to their long range and a larger contribution of Auger electrons is seen, although still 
on a smaller scale than in kilovoltage exposures. Significantly, the total short-range energy deposit 
per interaction is roughly constant for MV exposures, as a result of electron scattering's weak 
dependence on atomic number. 
Nanoscale energy and dose distributions
Figure 4 presents the nanoscale radial energy and dose distributions for an average ionising event 
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(that is, a radiation-nanoparticle interaction which produces at least one secondary particle) in 
nanoparticles of a selection of elements, under the same conditions as in Figure 3. 
As expected from Figure 3, there is considerable variability among the different elements, driven by
variations in Auger spectra. Differing Auger electron distributions can drive very high depositions 
in the immediate vicinity of the nanoparticle, broad peaks at moderate ranges (several hundred nm) 
or mixtures of these effects. These variations mean that it is challenging to predict which material 
delivers the highest dose enhancement at different distances from the particle, or which may offer 
the greatest radiosensitisation in general.
By contrast, megavoltage irradiations see only small variation with material. Again, this is in line 
with Figure 3, as the primary mechanisms of interaction (Compton and electron scattering) have 
very little dependence on atomic number for either cross-section or secondary electron spectra, 
giving broadly similar responses for all elements.
Because of the localised nature of interactions with these nanoparticles, for both cases these energy 
distributions correspond to very high local doses in the immediate vicinity of the nanoparticle, with 
kV exposures again showing significantly more variation than MV exposures. 
Biological Impacts
An approach based on the Local Effect Model (LEM) was used to assess the potential biological 
impact of these dose distributions, as presented in Figure 5.  A complex material dependency is 
once again seen for kilovoltage exposures, with two distinct local maxima seen in the rates of 
damage predicted by the LEM, centred approximately around Z=34 and Z=68. Elements in these 
energy ranges have their primary Auger electrons (from K and L shell, respectively) with energies 
around 9 to 10 keV, with numerous additional lower-energy electrons with energies around 2 keV 
and below, corresponding to ranges in water on the order of 1 μm and 100 nm, respectively. 
Material has a limited impact on MV Linac exposures – while there is a slight variation due to 
8
Optimising Element Choice for Nanoparticle Radiosensitisers McMahon et al
Auger electron contributions around Z=34 and 68, these are small, compared to the largely constant 
background independent of atomic number, driven by similar absorption of secondary electrons 
from the MV spectrum.
A small number of elements, including Europium, Gadolinium and Ytterbium, seem to lie 
significantly above the overall trend. A comparison of their physical properties suggests the 
common feature driving this effect is a relatively low density. This reduces self-absorption of 
secondary electrons, which can substantially increase the dose deposited in the vicinity of the 
nanoparticles.
Relative Biological Effectiveness (RBE) for nanoparticle-enhanced treatments in these conditions is
presented in Figure 6, calculated for cells exposed to 500 μg/mL of uniformly dispersed 20 nm 
diameter nanoparticles exposed to a dose of 2 Gy. The trends with atomic number largely 
mirror those in Figure 5, with significant variation seen in keV energies but relatively limited 
variation for MV Linac exposures. RBE calculations also introduce a dependency on the relative 
ionisation cross-section, however, which acts to significantly reduce the impact of low-Z agents at 
keV energies, and all materials at MeV energies. 
Discussion
Studies of nanoparticle contrast agents and sensitisers have focused on very high-Z agents. While 
this follows naturally from the macroscopic dose calculations, an increasing body of evidence 
suggests this is a poor guide for biological radiosensitisation. Expanding this field to encompass 
other nanoparticle compositions may not only enable better tuning of nanoparticle dose 
distributions, but also the development of novel nanoparticle designs exploiting other element's 
physical, chemical or biological properties.  
In this study we report on significant variations in predicted radiosensitisation between different 
elements which are not well described by macroscopic dose enhancement. These effects are driven 
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by differences in Auger electron spectra, which depend primarily on the irradiated element. The 
contribution of Auger electrons at short range initially rises due to increasing energy deposited by 
K-shell Auger electrons before falling as their energies become too great to deposit significant local 
energy and their yield falls due to competition from fluorescence. However, at higher atomic 
numbers L- and M-shell electrons become sufficiently energetic to contribute to radiosensitisation, 
leading to a peak around Z=68. Finally, at the upper limit of this study L-shell Auger electron 
energies also become too great and their local contribution begins to reduce. Alongside these trends 
is a variation in the range over which energy is primarily deposited, as can be seen in Figure 4. This 
may be an important factor in determining sensitising properties if nanoparticles are not uniformly 
distributed, as has been assumed in this analysis. 
Interestingly, for a clinical megavoltage source, Auger electrons are significantly less important 
across all elements, as interactions are dominated by Compton and electron scattering events, which
are primarily outer-shell interactions. This leads to a relatively material-independent prediction for 
sensitisation at megavoltage energies, and significantly lower overall effect.
This observation may prove very important for the usage of particles in a theranostic context, where
imaging and therapeutic functions are combined. The very different interactions at high and low 
energies may present challenges in these applications, such as greater than expected sensitisation in 
normal tissues to pre-treatment imaging delivered by CT in a contrast-enhanced setting. As a result, 
care must be taken to evaluate the interactions of these particles with all aspects of the treatment 
pathway.  
These results also present an avenue for validating models of the biological impacts of nanoparticle 
radiosensitisers. As the nanoscale dose model suggests a specific, complex dependence of 
radiosensitisation on nanoparticle material, comparing the radiosensitising properties of 
nanoparticles composed of different materials in biological systems offers a sensitive probe of the 
validity of these assumptions, in comparison to other possible radiosensitising mechanisms such as 
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biological or chemical stresses induced by the nanoparticles which would be expected to have a 
different material dependence. Such approaches of course depend on the development of 
nanoparticles with different compositions but similar biological uptake and localisation.
If validated, this wider range of material choices suggested by this analysis may open novel options 
for new nanoparticle designs which may make use of a range of elements in their design. This has 
the potential to offer more affordable therapeutic options, as well as new methods for optimisation 
of sensitisation, taking advantage of the chemical or biological properties of materials which may 
initially have been rejected as poor candidates for radiosensitisation due to their low atomic 
number. As noted above, this is also potentially significant for the development of theranostic 
nanoparticles, whether directly through improved X-ray absorption within the target, or by selecting
elements which are useful for alternative imaging techniques, such as MRI. 
One other observation in these results is the contribution of particle density to sensitisation. The 
least dense elements produce dose distributions which are predicted to lead to significantly greater 
sensitisation than than would be expected based on atomic number alone, which is believed to be 
driven by low-energy secondary electrons having an increased probability of escape. This suggests 
that less dense particle preparations (e.g. combining some atoms of a high-Z material in a crystal or 
organic molecule with lighter elements) may drive superior radiosensitisation than a similar mass of
material contained in denser pure nanoparticles (subject to the ability to deliver a sufficient total 
concentration of contrast agent). Such an approach has been taken in development of hafnium-oxide
and gadolinium-based nanoparticles, which have reported significant radiosensitising properties 
(13, 14) and are moving towards clinical trials.
It is important to note that this is a preliminary exploration of the impact of material choice in 
nanoparticle radiosensitisation, only considering pure elemental nanoparticles of one size and 
limited energy selections to illustrate underlying mechanisms. Specific real exposure conditions are 
likely to differ, with different irradiation energies leading to changes in interaction cross-sections, 
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and nanoparticle size having a significant impact on the low-energy portion of the secondary 
electron spectra.
Significant material-specific tuning is likely to be possible, taking into greater account the particular
characteristics of its secondary electron energy deposition and particle design. Additionally, a 
detailed optimisation of nanoparticle design would need to investigate not only the physical 
properties of these materials but also their biological and chemical comparability and any 
associated coatings, including how this impacts on both the quantity and uniformity of nanoparticle 
delivery. However, the current analysis is still sufficient to demonstrate that there is a viable 
physical rationale not to focus exclusively on the heaviest elements when developing 
radiosensitising nanoparticles. 
Conclusion
In conclusion, these results present a much more complex picture of the radiosenisiting properties 
of heavy atom nanoparticles than would be expected from their mass energy absorption coefficients 
alone. This suggests that there is considerable merit in investigating nanoparticle preparations 
which make use of other light elements, to potentially optimize the radiation-related sensitising 
effect and to make best use of the wide range of chemical and biological properties which would be 
accessible through novel nanoparticle designs.
Experimental Section
Analytic macroscopic dose enhancement calculations
To provide a reference against which to compare the nanoscale calculations, macroscopic dose 
enhancement factors were calculated for all elements. Based on the assumption that nanoparticle 
contrast agents can be considered as homogeneously distributed throughout a target volume, 
potential dose enhancement per unit mass of contrast agent can be approximated simply as the ratio 
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of the mass energy absorption coefficients, DER(Z )=
μZ
μtissue . This can then be scaled by the 
particle concentration to give an actual dose enhancement value.  These values were calculated for 
all materials as a function of radiation energy based on values from NIST (25). 
For ease of comparison between different materials, a normalised ratio has been calculated at each 
energy, normalising each material's dose enhancement ratio to the maximum contrast possible at 
that energy. This offers an easier comparison between different materials, as the maximum 
achievable dose enhancement varies greatly as a function of energy.
Monte Carlo nanoparticle dose deposition calculations
Radiation-nanoparticle interactions and resulting radial dose distributions were modelled using 
Geant4.9.6 (patch 3) (26), simulating individual 20 nm diameter nanoparticles placed within the 
centre of a 10 μm a side cube of water. Livermore low-energy physics models were used for 
radiation transport within the nanoparticle volume, with Geant4-DNA models used in the 
surrounding water volume (27). The use of water as a detector volume for the dose distribution is 
necessarily an approximation to biological systems which contain a wider range of different 
chemical species, but is a necessary simplification due to the current lack of appropriately detailed 
models of low-energy radiation interactions with organic systems.
Nanoparticles were modelled as pure spheres of individual elements ranging from Z=14 to Z=80, 
with material properties (isotope distribution, density, etc)  taken as Geant4 defaults for STP, based 
on the NIST reference values. Elements which were liquid or gaseous under these conditions were 
not considered for further analysis due to poor statistics.
Initially, interactions were modelled using monochromatic keV X-rays. As ionisation cross-sections 
and Auger spectrum depend strongly on photon energy for keV X-rays, individual X-ray energies 
were used for each material. Energies were set to 20 keV above the K-edge of the material being 
exposed (ranging from 22 to 102 keV). This enables comparisons to be made between all elements 
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following similar ionising events, which primarily occur in inner shells to allow for the full impact 
of Auger electrons to be investigated. Total primary particles simulated ranged from 8×108 to 
1.6×109 photons, depending on nanoparticle and beam energy, delivered as a 20 nm diameter beam 
exposing the whole particle.
Clinically-relevant Megavoltage exposures were modelled using both the photon and electron 
components of a 6 MV Linac spectrum at the 80% PDD, obtained through Monte Carlo simulation 
as described previously (23, 28). In these simulations, 3×108 primary photons sampled from a 
published 6 MV Linac spectrum (29) were directed in a 10 cm diameter beam along the axis of a 
cylindrical block of water of 20 cm length and diameter. These simulations scored dose along the 
beam direction as well as the spectrum of both photons and electrons at the 80% dose-depth 
position, 8.7 cm below the surface. To model nanoparticle irradiations, these spectra were scaled 
down to nanometer scales and used to expose individual nanoparticles, as was the case for 
kilovoltage photons. Once again, radial doses and secondary particle distributions were calculated 
for nanoparticles with atomic numbers ranging from 14 to 80. These simulations modelled 1.6×109 
photons, and approximately 2.5×107 electrons, based on the input phase space, scaled to a 20 nm 
diameter beam.
For both types of exposure, all secondary particles emitted from the nanoparticles were scored, 
identifying the process which led to their emission, as well as the dose deposited in concentric 2 nm
shells around the nanoparticle, out to a range of 1 μm from the nanoparticle. 
For each nanoparticle/radiation combination studied in this work, the full secondary particle 
distributions as well as the radial dose distributions (broken down by contributing process) are 
provided in the Supplementary Information to support further investigation.
Nanoscale Radiosensitisation Calculations
An approach based on the Local Effect Model (LEM-1) was used to evaluate the potential 
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biological impact of these nanoscale dose depositions. The LEM was developed to describe the 
biological effectiveness of highly charged ions (20, 21), which have a significantly higher 
biological effectiveness than a similar dose of X-rays. This technique, as well as its application to 
nanoparticle-enhanced therapy, has been described in detail elsewhere (20, 23), and is reviewed 
below for completeness.
The LEM suggests that the biological effectiveness of heterogeneous exposures can be understood 
in terms of the dose at each point within the cell, rather than the average dose to the cell. 
Specifically, it postulates that cells die to the formation of 'lethal lesions', with survival given by
S (N )=e−N , where N is the number of lesions formed in the cell. N can be expressed as
N (D )=ln(S{D}) , where S(D) is the survival of cells following exposure to a uniform dose D 
of X-rays.
For heterogeneous exposures, the LEM assumes that a) the microscopic lesion density at  given 
dose is the same as that across the whole cell; and b) the total number of lesions within the cell is 
dependent on the integral of the probability of a lesion forming at each point. Thus, the total number
of lesions is given by N tot=∫N (Dr) dVV , where Dr  is the dose delivered to the point r, 
exposing a fraction of the total cell volume given by dVV . As a result of non-linear terms in the 
dose response function, the localised doses of highly charged ion therapies drive significantly more 
cell killing than a uniform exposure to the same average dose of X-rays.
These concepts can also be applied to nanoparticle-enhanced therapies, and have successfully 
demonstrated more accurate prediction of radiation sensitization in nanoparticle enhanced therapies,
suggesting these effects may play an important role in nanoparticle sensitization (22, 23). 
In this work, the number of lesions induced per nanoparticle-radiation interaction, N NP , was 
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calculated by summing the damage as a function of distance from the nanoparticle, assuming the 
linear-quadratic model of response to uniform exposures, S (N)=e−αD−βD
2
. This gives a total 
number of lesions as N NP=∫(α D NP(r )+βD NP(r )2)dV /V , where Dnp(r) is the radial dose 
distribution around a nanoparticle following an ionising event (as illustrated in Figure 4). For ease 
of comparison, the potential cell killing impact of a single nanoparticle-radiation interaction was 
equated to a uniform X-ray dose D Eff , defined as N NP=α D Eff+βDEff
2 .
For the purposes of this analysis, the calculated radial dose distribution is smoothed using a 
spherically symmetric Gaussian kernel, as in ion therapy approaches (20), with σ=10 nm. This 
represents the diffusion of potentially damaging biological and chemical species following initial 
radiation interactions while preserving the total energy deposited in the system. This has several 
effects, including a reduction in sensitivity to statistical uncertainties and the removal of non-
physical dose peaks at extremely small radial positions. 
Finally, these effects are converted into a Relative Biological Effectiveness (RBE). The RBE is 
defined as RBE=
DX
DNP
 where Dx is the reference X-ray dose, chosen to be 2 Gy in this work, 
and DNP is the dose which yields equal survival in the presence of nanoparticles. The number of 
lethal lesions (and thus survival) was calculated for a given condition according to
N tot=N X+ηN np , where N X  is the number of lesions induced by the uniform X-ray dose,
N NP is the number of lesions induced per nanoparticle-radiation interaction, and η  is the 
number of nanoparticle-radiation interactions in a given exposure. η  is calculated as the product 
of the delivered dose, the number of interactions per nanoparticle per Gray for the particle/radiation 
type under consideration (taken from ionisation cross-sections for monoenergetic keV exposures, 
and the phase space calculations for linac exposures) and the number of particles present in the 
volume, taken to be 500 μg/mL in this work.
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It is important to note that analysis assumes that all of the volume around the nanoparticle are 
uniformly sensitive to ionising radiation. While this may not always apply for nanoparticles which 
may, for example, be sequestered far from DNA and other sensitive targets by active cellular 
processes, it is a useful initial guide to sensitising impacts.
Supporting Information
The supporting information contains simulation results for both keV and Linac exposures used to 
generate data presented in this article. Full sets of data are available containing radial energy 
deposit distributions per ionising event, secondary particles per ionising event, and total event 
counts for simulations. 
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Figures
Figure 1: Comparison of Mass Energy Absorption coefficients for soft tissue and a range of heavy 
elements (top). Although higher-Z metals generally have the highest absorption coefficient, this is 
not always the case, with edge structure introducing significant variation. This is similarly apparent 
in the ratio of metal absorption to that of soft tissue (bottom), which shows gold’s absorption is 
surpassed by other metals over a wide range of the kilovoltage region.
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Figure 2: Normalised enhancement per unit mass for a range of materials and energies. At each 
energy, the enhancement ratio has been normalised to that of the maximum at that energy. Clear 
structure can be seen at low energies, with bands corresponding to K-, L- and M-shell absorption. 
At higher energies, little variation in potential enhancement is seen as absorption is dominated by 
Compton interactions. 
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Figure 3: Top: Total energy emitted from a nanoparticle by various processes following an ionising 
event as a function of atomic number, for tuned keV irradiation (left) or 6 MV Linac exposure 
(right). At keV energies, photoelectrons and fluorescence dominate these effects, while for MV 
energies ionisations by secondary electrons in the beam spectrum dominate. Bottom: Distribution of
energy deposited within 1 micron of a nanoparticle centre per ionising event, broken down 
according to contributions of various processes. At keV energies, the majority of energy is 
deposited by Auger electrons, which have a complex energy dependence, while for MV interactions
electron impact remains the dominant contribution.
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Figure 4: Nanoscale radial energy distributions (top) and dose distributions (bottom) around 20 nm 
nanoparticles of various metals following a single ionising event caused by either tuned keV X- 
rays (left) or a 6 MV Linac spectrum (right). Significant complexity is seen in keV irradiations, with
differing energy distributions depending on the characteristic Auger cascade produced by the 
material. By contrast, MV irradiation produces similar energy distributions in all cases, as Auger 
electrons play a reduced role. Bottom: For both spectra, there remain high localised doses in the 
vicinity of high-Z nanoparticles.
24
Optimising Element Choice for Nanoparticle Radiosensitisers McMahon et al
Figure 5: Biological effects of nanoparticle-radiation interactions, in terms of effective dose 
deposited by a single ionising event, for cells with α/β ratios of either 3 (blue) or 10 (green) for keV
(left) and MV (right) exposures. For keV irradiation, significant variation is seen, with several 
distinct peaks of effect, reflecting nanoscale Auger dose distributions. By contrast, MV interactions 
are relatively slowly-varying over the entire range of atomic number. 
Figure 6: Relative Biological Effectiveness (RBE) predicted by the LEM for addition of 
nanoparticles to cells at concentrations of 500 μg/mL for 2 Gy exposures using kilovoltage (left) 
and megavoltage (right) exposures. These trends largely follow those seen in in the per-interaction 
rates in Figure 5, but there is also a significant contribution from the interaction cross-section of the 
radiation, reducing the impact of the lightest elements at keV energies, and all elements at MeV 
energies.
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